Medexus Provides Update on Progress of Commercialization of GRAFAPEX (treosulfan) for Injection @MedexusInc #SpecialtyPharma #Chemicals #Pharmaceutical #Biotechnology #HealthCare #Medical #Pharmaceuticals #OTC #OTCMarkets #OTCStocks #TSX #Investing
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - April 7, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to provide a business update on the progress of the commercial launch of GRAFAPEX™ (treosulfan) for Injection in the United States and announce company management's participation in two upcoming investor conferences.Medexus has seen an encouraging market response to GRAFAPEX™ in the weeks since the February 24 commercial launch of the product. Several procedures...
http://dlvr.it/TK0lqC
http://dlvr.it/TK0lqC
Comments
Post a Comment